| Q46877438 | An improved dosing schedule for ivermectin as a microfilaricidal agent against onchocerciasis |
| Q39512785 | Avoidable blindness |
| Q39001906 | Chemokines in onchocerciasis patients after a single dose of ivermectin |
| Q44849145 | Decrease in adverse reactions after repeated ivermectin treatment in onchocerciasis |
| Q39559607 | Doing well while fighting river blindness: the alignment of a corporate drug donation programme with responsibilities to shareholders |
| Q37159863 | Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis |
| Q33646509 | Effect of single-dose ivermectin therapy on human Onchocerca volvulus infection with onchocercal ocular involvement. |
| Q52443926 | Effects of repeated ivermectin treatment in onchocerciasis. |
| Q38849178 | Evaluation of Community-Directed Operation of Black Fly Traps for Entomological Surveillance of Onchocerca volvulus Transmission in the Madi-Mid North Focus of Onchocerciasis in Northern Uganda |
| Q46453620 | Evaluation of Community-Directed Operation of Black Fly Traps for Entomological Surveillance of Onchocerca volvulus Transmission in the Madi-Mid North Focus of Onchocerciasis in Northern Uganda |
| Q35743788 | Impact of ivermectin on illness and disability associated with onchocerciasis |
| Q52448294 | Improvement in severe onchocercal skin disease after a single dose of ivermectin. |
| Q67557767 | Intramuscular onchocercoma. Case report |
| Q24201374 | Ivermectin for onchocercal eye disease (river blindness) |
| Q33940718 | Ivermectin for onchocercal eye disease (river blindness). |
| Q52454577 | Ivermectin treatment of onchocerciasis. |
| Q39475321 | Ivermectin-facilitated immunity in onchocerciasis. Reversal of lymphocytopenia, cellular anergy and deficient cytokine production after single treatment |
| Q52450257 | Longitudinal study of lesions of the posterior segment in onchocerciasis. |
| Q90104692 | Meta-analysis of epilepsy prevalence in West Africa and its relationship with onchocerciasis endemicity and control |
| Q33648556 | Ocular manifestations of onchocerciasis in a rain forest area of west Africa |
| Q68512995 | Onchocerciasis |
| Q34770839 | Operational lessons from 20 years of the Mectizan Donation Program for the control of onchocerciasis |
| Q40726359 | Preliminary observations on the distribution of ivermectin in Nigeria for control of river blindness |
| Q37573002 | Serosurveillance to monitor onchocerciasis elimination: the Ugandan experience |
| Q35954279 | The life and times of ivermectin - a success story |
| Q52460898 | The relative systemic availability of ivermectin after administration as capsule, tablet, and oral solution. |